All Case Post Marketing Drug Use Result Survey for Blinatumomab in Japan (20170655) (Blinatumomab All Case PMS Japan)

28/11/2018
20/09/2023
EU PAS number:
EUPAS26530
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Study_20170655_Blinatumomab_Japan_PMS_Protocol_Amgen Format_ver1.0

English (647.7 KB - PDF) View document
Study results
Study results

20170655 ORSR Abstract_Redacted

English (127.45 KB - PDF) View document
Study report
Other information